Threshold values of 37.3 and 67.1 points were identified as optimal cutoffs for high-risk diseases and CRC discrimination, respectively.<h4>Conclusions</h4>We developed and validated two ML-based models integrating Septin9 methylation with routine serum biomarkers for early detection and differentiation of CRC. Here, SEPTIN9 is linked to colorectal carcinoma.